Developing imaging agents for specific types of tau-related brain diseases
In Vitro and In Vivo Characterization of PET Radiotracers for the 4R Variant of Tau
This study is working on a new imaging tool that helps doctors spot certain brain diseases, like progressive supranuclear palsy and corticobasal degeneration, more accurately, so patients can get better diagnoses and treatments that are just right for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10940635 on NIH RePORTER |
What this research studies
This research focuses on creating a new type of imaging agent called a PET radiopharmaceutical that can specifically identify 4-repeat tauopathies, which are brain diseases like progressive supranuclear palsy and corticobasal degeneration. By improving the sensitivity and specificity of these imaging agents, the research aims to better differentiate between various tau-related conditions and assess the effectiveness of new treatments targeting tau. Patients will benefit from enhanced diagnostic capabilities that could lead to more tailored and effective therapies. The research involves both laboratory studies and testing in animal models to evaluate the performance of these new agents.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with 4-repeat tauopathies such as progressive supranuclear palsy, corticobasal degeneration, or frontotemporal lobar degeneration.
Not a fit: Patients with other types of dementia or neurological conditions unrelated to tauopathies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatment options for patients with tauopathies.
How similar studies have performed: Previous research has shown promise in developing PET agents for imaging tau aggregates, but this specific focus on 4-repeat tauopathies is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mathis, Chester a — University of Pennsylvania
- Study coordinator: Mathis, Chester a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.